MAPT and Alzheimer disease: However, in AD and Tauopathies stressors are assumed to result in Tau hyperphosporylation and GSK3β hyperactivity with decreased phosphatase activity [13]; but the SHSY-5Y cells were not exposed to any stressor, or Tau activator.